100 Active Studies

Pulmonary Embolism Clinical Trials Near You

Find 100 actively recruiting pulmonary embolism research studies near you. Connect with study sites, check eligibility, and explore new treatment options.

100
Active Trials
317+
Locations
61,015
Participants Needed

Recruiting Studies

RecruitingNCT07064473

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. ...

10 locations(Anniston, Fairhope, Guntersville)
11,800 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT05390892

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients...

8 locations(Baltimore, Duluth, Columbia)
6,000 participants
Brigham and Women's Hospital
View Study Details
RecruitingNCT04649242

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents....

10 locations(Birmingham, Scottsdale, Tempe)
2,100 participants
Pfizer
View Study Details
RecruitingNCT06012240

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and face, but hair loss can happen on any part of the bod...

10 locations(Birmingham, Glendale, Phoenix)
1,500 participants
AbbVie
View Study Details
RecruitingNCT04678154

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT

The proposed study is a multi-center, prospective randomized controlled trial comparing current standard of care treatment to the SEXTANT treatment protocol in patients with Type III open fractures of...

10 locations(Redwood City, San Francisco, San Francisco)
1,200 participants
Major Extremity Trauma Research Consortium
View Study Details
RecruitingNCT06628908

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN)....

10 locations(Anniston, Birmingham, Daphne)
1,100 participants
Vertex Pharmaceuticals Incorporated
View Study Details
RecruitingNCT07104383

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic ef...

10 locations(Birmingham, Birmingham, Huntsville)
1,100 participants
Viking Therapeutics, Inc.
View Study Details
RecruitingNCT06061861

Kaiser Permanente Evaluating Nutritional Interventions in Food-Insecure High-Risk Adults Study

The goal of this randomized controlled trial is to compare the effect of receiving 6 months of monetary support for healthy food through a food delivery platform on change in glycosylated hemoglobin (...

2 locations(Pasadena, Pleasanton)
1,100 participants
Kaiser Permanente
View Study Details
RecruitingNCT05535946

ABTECT - Maintenance

This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with m...

10 locations(Birmingham, Dothan, Guntersville)
1,050 participants
Abivax S.A.
View Study Details
RecruitingNCT06948422

A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)

The GZPL master protocol will support 2 independent studies, J2A-MC-GZL1 (GZL1) and J2A-MC-GZL2 (GZL2). The purpose of this study is to create a framework to evaluate the safety and efficacy of orforg...

10 locations(Phoenix, Covina, Northridge)
974 participants
Eli Lilly and Company
View Study Details
RecruitingNCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from pati...

10 locations(Birmingham, Mobile, Anchorage)
960 participants
PedAL BCU, LLC
View Study Details
RecruitingNCT06914895

A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 49 week...

10 locations(Goleta, Santa Clarita, Aurora)
905 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06671002

Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial

This trial is being completed to compare two commonly used options to treat pain after discharge from surgery. Participants that undergo tonsil removal, gallbladder removal, and knee scope will be eli...

4 locations(Los Angeles, Palo Alto, Ann Arbor)
900 participants
University of Michigan
View Study Details
RecruitingNCT07076199

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

This study compares insulin icodec, an insulin taken once a week to insulin glargine, an insulin taken once a day. The study medicine will be investigated in participants with type 1 diabetes. The stu...

10 locations(Cullman, Concord, Escondido)
877 participants
Novo Nordisk A/S
View Study Details
RecruitingNCT05681351

CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)

The purpose of this study is to evaluate the safety and tolerability of olezarsen in participants with SHTG....

10 locations(Los Angeles, San Diego, Tarzana)
800 participants
Ionis Pharmaceuticals, Inc.
View Study Details
RecruitingNCT04262466

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Brenetafusp (IMC-F106C) is an immune-mobilizing monoclonal T cell receptor against cancer (ImmTAC ®) designed for the treatment of cancers positive for the tumor-associated antigen PRAME. This is a fi...

10 locations(La Jolla, Los Angeles, Sacramento)
727 participants
Immunocore Ltd
View Study Details
RecruitingNCT07088068

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insul...

10 locations(Scottsdale, Huntington Beach, Atlanta)
723 participants
Sanofi
View Study Details
RecruitingNCT04638647

Secukinumab Open Label Roll-over Extension Protocol

The purpose of this study is to assess long term safety in participants who have completed a Novartis trial with secukinumab, have been judged by the investigator to benefit from continued treatment w...

10 locations(Fullerton, La Mesa, San Leandro)
715 participants
Novartis Pharmaceuticals
View Study Details
RecruitingNCT05099770

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-bio...

10 locations(Tucson, Beverly Hills, Glendora)
685 participants
Prokidney
View Study Details
RecruitingNCT05470205

Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal

This is an open-label, non-randomized trial that will be conducted at three clinical sites, Thomas Jefferson University (TJU), the Hospital of the University of Pennsylvania (HUP) and University of Be...

3 locations(Philadelphia, Philadelphia, Bern)
660 participants
Thomas Jefferson University
View Study Details
RecruitingNCT06994442

Optimizing Pain Treatment in Children On Mechanical Ventilation

In this clinical trial, investigators want to learn more about using non-opioid pain medications for children with acute respiratory failure. Right now, doctors give these children opioids to help wit...

10 locations(Little Rock, Washington D.C., Ann Arbor)
644 participants
Weill Medical College of Cornell University
View Study Details
RecruitingNCT05156398

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years with episodic migraine....

10 locations(Fort Smith, Hawthorne, La Mesa)
640 participants
Pfizer
View Study Details
RecruitingNCT06972472

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes

The main purpose of this study is to see how orforglipron, compared with placebo, helps improve glycemic control in participants with obesity or with overweight and type 2 diabetes. This trial is part...

10 locations(Tucson, San Ramon, Santa Ana)
600 participants
Eli Lilly and Company
View Study Details
RecruitingNCT05723198

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in children from 6 years to less than 18 ye...

10 locations(Birmingham, Birmingham, Scottsdale)
595 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06873945

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

The purpose of the study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the treatment of alopecia areata. Alopecia areata is a disease that causes hair loss o...

10 locations(Hot Springs, Brea, Encinitas)
550 participants
Pfizer
View Study Details
RecruitingNCT06072131

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL

Part 1: This is a 5 Arm study primarily to determine the best dose out of the two dose levels of Belinostat and Pralatrexate combined with CHOP/COP in newly diagnosed PTCL patients based on Safety for...

10 locations(Clovis, Santa Monica, Pembroke Pines)
504 participants
Acrotech Biopharma Inc.
View Study Details
RecruitingNCT06481891

A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

The main purpose of the study is to determine the changes in symptoms and functional limitations in participants with symptomatic hypertrophic cardiomyopathy (HCM) treated with sotagliflozin as compar...

10 locations(Scottsdale, Los Angeles, Pomona)
500 participants
Lexicon Pharmaceuticals
View Study Details
RecruitingNCT05591118

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with anticoagulation alone (No-CDT) in 500 patients wit...

10 locations(Birmingham, Palo Alto, Sacramento)
500 participants
NYU Langone Health
View Study Details
RecruitingNCT05267821

Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS

The TRIPS study is a prospective, multi-center, double-blind, adaptively randomized, placebo-controlled clinical trial of the drug anakinra for reversal of moderate to severe hyperinflammation in chil...

10 locations(Birmingham, Little Rock, Los Angeles)
500 participants
Nationwide Children's Hospital
View Study Details
RecruitingNCT06081894

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM

This clinical trial will study the effects of aficamten (versus placebo) on the quality of life, exercise capacity, and clinical outcomes of patients with non-obstructive hypertrophic cardiomyopathy....

10 locations(Birmingham, Anchorage, La Jolla)
500 participants
Cytokinetics
View Study Details
RecruitingNCT05816382

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

The main aim is to evaluate the safety and tolerability of TAK-861 on participants with type 1 narcolepsy, who were exposed to previously tested doses of TAK-861....

10 locations(Birmingham, Redwood City, Santa Ana)
500 participants
Takeda
View Study Details
RecruitingNCT05766670

Intramedullary Calcium Sulfate Antibiotic Depot

The goal of this randomized clinical trial is to study the best treatment for open lower leg fractures to prevent infection. The main questions it aims to answer is if treating tibia fracture patients...

10 locations(Los Angeles, Macon, Lexington)
497 participants
Wake Forest University Health Sciences
View Study Details
RecruitingNCT06948435

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1

GZL1 is an independent study conducted under the GZPL master protocol. GZL1 will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweig...

10 locations(Phoenix, Covina, Northridge)
487 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06952530

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2

GZL2 is an independent study conducted under the GZPL master protocol. GZL2 study will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or ov...

10 locations(Phoenix, Covina, Northridge)
487 participants
Eli Lilly and Company
View Study Details
RecruitingNCT07003919

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

The primary objective of this study is to assess the 6-month safety of DBV712 250 micrograms (mcg) in subjects 1 through 3 years of age with peanut allergy....

10 locations(Birmingham, Birmingham, Tucson)
480 participants
DBV Technologies
View Study Details
RecruitingNCT06962280

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

The main purpose of this study is to find out how well and how safely tirzepatide works long-term in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last abo...

10 locations(Bonita, Escondido, Newport Beach)
465 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06568042

Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

The purpose of this study is to evaluate how safe and how well a treatment works compared to placebo for people with nerve pain that begins in their feet and moves up the leg to just below the knee. ...

10 locations(Chandler, Phoenix, Fresno)
450 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06339008

A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. Participants can expect study participation to last up to...

10 locations(Huntington Beach, Inglewood, Laguna Niguel)
450 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06542874

A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

The study will look at how well different doses of a new medicine called NNC0487-0111 help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which ca...

10 locations(Santa Ana, Waterbury, Waterbury)
432 participants
Novo Nordisk A/S
View Study Details
RecruitingNCT06953869

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

This is a multicenter, double-blind, randomized study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon and matching placebo in male and female pediatric participants with...

3 locations(Winter Park, Charlotte, San Antonio)
420 participants
Vanda Pharmaceuticals
View Study Details
RecruitingNCT07000136

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH

This is a study to evaluate the efficacy and safety of AZD0780 in adults with HeFH and elevated LDL-C, either with clinical ASCVD and LDL-C levels of 55 mg/dL or higher or without clinical ASCVD and L...

10 locations(Chula Vista, Garden Grove, Lake Forest)
405 participants
AstraZeneca
View Study Details
RecruitingNCT06351631

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

The primary purpose of the study is to transition participants into an extension study to collect long-term safety and efficacy data. The study will include participants who are safely tolerating bome...

10 locations(Ann Arbor, Durham, Columbus)
400 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06686121

Improving Mobility After Revascularization in Peripheral Artery Disease

Lower extremity revascularization combined with supervised exercise significantly improves walking performance compared to revascularization alone in people who have PAD without limb threatening ische...

7 locations(Tucson, Downey, Atlanta)
386 participants
Northwestern University
View Study Details
RecruitingNCT06857955

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

The purpose of this study is to evaluate the efficacy, safety and tolerability of QCZ484 or placebo, given subcutaneously, every 6 months, at different dose levels in patients with mild to moderate hy...

10 locations(Andalusia, Tucson, Garden Grove)
380 participants
Novartis Pharmaceuticals
View Study Details
RecruitingNCT04560673

Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

This phase II trial investigates how well duloxetine and neurofeedback training work in treating patients with chemotherapy induced peripheral neuropathy. Duloxetine is a type of serotonin and norepin...

2 locations(Houston, Houston)
380 participants
M.D. Anderson Cancer Center
View Study Details
RecruitingNCT02332668

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Researchers are looking for new ways to treat children with different types of melanoma (skin cancer), solid tumors, and lymphomas (blood cancers) that are any of these: * Advanced, which means cance...

10 locations(Aurora, Boston, New York)
370 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06628362

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of CT-388 at low, middle, and high doses in participants who...

10 locations(Anniston, Birmingham, Birmingham)
360 participants
Carmot Therapeutics, Inc.
View Study Details
RecruitingNCT04939090

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

This phase III trial compares the effects of olanzapine versus megestrol acetate in treating loss of appetite in patients with cancer that has spread to other places in the body (advanced). Olanzapine...

10 locations(Gilbert, Goodyear, Peoria)
360 participants
Alliance for Clinical Trials in Oncology
View Study Details
RecruitingNCT07133308

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

This study evaluates the safety and effectiveness of deuruxolitinib in adolescents aged 12 to less than 18 years who have 50% or greater scalp hair loss....

10 locations(Birmingham, Los Angeles, San Diego)
355 participants
Sun Pharmaceutical Industries, Inc.
View Study Details
RecruitingNCT04176172

Optimizing Tobacco Use Treatment for PLWHA

The advent of anti-retroviral therapy (ART) for people living with HIV/AIDS (PLWHA) substantially improved life expectancy but has also led to the critical need to address modifiable risk factors asso...

2 locations(Chicago, Philadelphia)
340 participants
University of Pennsylvania
View Study Details
RecruitingNCT05018585

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with oral Vitamin D supplementation, to preserve endogeno...

10 locations(Newport Beach, Palo Alto, San Diego)
330 participants
Diamyd Medical AB
View Study Details
RecruitingNCT03922724

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Background: Lymphoma is a type of blood cancer. Blood cell transplant can cure some people with lymphoma. Researchers want to see if they can limit the complications transplant can cause. Objective:...

2 locations(Bethesda, Minneapolis)
330 participants
National Cancer Institute (NCI)
View Study Details
RecruitingNCT06297603

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and renal impairment, with inadequate glycemic control on ...

10 locations(Huntsville, Sun City West, Apple Valley)
320 participants
Eli Lilly and Company
View Study Details
RecruitingNCT04787042

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

This is a multiphase, multicenter study, which includes a Phase 1a open-label, dose escalation monotherapy study of ST-067 given as an SC injection with or without obinutuzumab \[Gazyva®\] pre-treatme...

6 locations(Scottsdale, Denver, New Haven)
316 participants
Simcha IL-18, Inc.
View Study Details
RecruitingNCT05615844

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

The Beads vs Vac trial is a multi-centre randomized controlled trial of 312 participants with a severe open tibia fracture requiring multiple irrigation and debridement surgeries. Eligible participant...

10 locations(Chandler, Los Angeles, Los Angeles)
312 participants
University of Maryland, Baltimore
View Study Details
RecruitingNCT06619860

Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy, safety, and tolerability of VX-993 in participants with pain associated with Diabetic Peripheral Neuropathy (DPN)...

10 locations(Cullman, Bakersfield, La Mesa)
300 participants
Vertex Pharmaceuticals Incorporated
View Study Details
RecruitingNCT05238519

Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)

The overall goal of this study is to promote awareness of Familial Hypercholesterolemia (FH). The investigators aim to enroll patients with suspected FH into the study and will randomize them to recei...

2 locations(Duluth, Duluth)
300 participants
Essentia Health
View Study Details
RecruitingNCT06274801

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study...

10 locations(Fresno, Los Angeles, Sacramento)
300 participants
GB002, Inc.
View Study Details
RecruitingNCT04005378

Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs

Maintaining treatment engagement is critical for first episode psychosis patients to experience gains possible with coordinated specialty care (CSC). This study is designed to identify CSC participant...

3 locations(Lauderdale Lakes, Grand Rapids, Kalamazoo)
300 participants
Northwell Health
View Study Details
RecruitingNCT06326047

A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes

This study will look at how well a new medicine called NNC0519-0130 helps people with type 2 diabetes lower their blood sugar and body weight. The study will test up to 7 different doses of NNC0519-01...

10 locations(Chula Vista, Fresno, Fresno)
288 participants
Novo Nordisk A/S
View Study Details
RecruitingNCT06789913

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation

This is a 3-part Phase 2 randomized study evaluating the safety and efficacy of the mutant-selective PI3Kα inhibitor, RLY-2608, in adults and children with PIK3CA Related Overgrowth Spectrum (PROS) an...

9 locations(Little Rock, Los Angeles, San Francisco)
277 participants
Relay Therapeutics, Inc.
View Study Details
RecruitingNCT06933472

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

The goal of this clinical trial is to learn if AP301 could work in the patients receiving maintenance dialysis with elevated blood phosphate. The main questions it aims to answer are: * Does AP301 lo...

10 locations(Lone Tree, Orange, Fort Myers)
264 participants
Alebund Pharmaceuticals
View Study Details
RecruitingNCT04416269

Oral Anti Diabetic Agents in the Hospital

This randomized controlled clinical trial will assess whether continuation of home oral antidiabetic agents during hospitalization can be used as a safe and effective alternative to insulin therapy in...

3 locations(Atlanta, Atlanta, Atlanta)
260 participants
Emory University
View Study Details
RecruitingNCT06246799

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

The primary purpose of this study is to evaluate the efficacy, durability, and mechanism of HbA1c reduction produced by the combination of pioglitazone plus tirzepatide compared to metformin plus sita...

2 locations(San Antonio, San Antonio)
256 participants
The University of Texas Health Science Center at San Antonio
View Study Details
RecruitingNCT05180773

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized placebo controlled trial of bromocriptine therapy to evaluate its impact on my...

10 locations(Birmingham, Tucson, La Jolla)
250 participants
Dennis M. McNamara, MD, MS
View Study Details
RecruitingNCT05695027

Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study

The objective of this study is to determine if a combination of oral nicotinamide and pyruvate (N\&P) can maintain eye health as compared to placebo while standard-of-care intraocular pressure-lowerin...

3 locations(Palo Alto, New York, New York)
250 participants
Columbia University
View Study Details
RecruitingNCT04031677

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dediffer...

10 locations(Phoenix, Duarte, Orange)
250 participants
European Organisation for Research and Treatment of Cancer - EORTC
View Study Details
RecruitingNCT04433572

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the effect of Temsirolimus Perivascular Injection 0.1 mg/mL on the incidence of ischemia-driven major amputation, clinical...

2 locations(Houma, Dallas)
250 participants
Mercator MedSystems, Inc.
View Study Details
RecruitingNCT04628767

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

This phase II/III trial compares the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery in treating patients with upper urinary tract cancer. Immunotherapy with monoc...

10 locations(Kingman, Fort Smith, Little Rock)
249 participants
National Cancer Institute (NCI)
View Study Details
RecruitingNCT07112872

A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes

This multicenter, randomized, double-blind, placebo- and open-label active comparator-controlled, parallel-group, dose-range-finding, Phase II study aims to evaluate the efficacy, tolerability, and sa...

10 locations(Lake Forest, Rancho Cucamonga, Spring Valley)
240 participants
Hoffmann-La Roche
View Study Details
RecruitingNCT06897475

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabetes who are not at HbA1c goal when treated with a sta...

10 locations(Phoenix, Santa Ana, Ocala)
240 participants
Eli Lilly and Company
View Study Details
RecruitingNCT04752774

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

The purpose of the study is to assess the safety and efficacy of increasing doses of IPN10200 with the aim to evaluate the Pharmacodynamics (PD) profile of IPN10200 and to establish the total IPN10200...

10 locations(Downey, Overland Park, Farmington Hills)
240 participants
Ipsen
View Study Details
RecruitingNCT05983250

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

This study will evaluate the efficacy of TNX-103 (oral levosimendan) compared with placebo in subjects with PH-HFpEF as measured by the change in 6-Minute Walk Distance (6 MWD; Day 1 to Week 12)....

10 locations(Birmingham, Tucson, Little Rock)
230 participants
Tenax Therapeutics, Inc.
View Study Details
RecruitingNCT07029711

A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

The purpose of this study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the possible treatment of severe alopecia areata. Alopecia areata is a condition that...

10 locations(Miami, Tamarac, Indianapolis)
225 participants
Pfizer
View Study Details
RecruitingNCT05101187

Olorofim Aspergillus Infection Study

The purpose of this study is to compare treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with IFD caused by proven IA or probable lower respirator...

10 locations(Birmingham, Duarte, Sacramento)
225 participants
F2G Biotech GmbH
View Study Details
RecruitingNCT06777901

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone

The goal of this clinical trial is to learn if the Auryon Atherectomy System with balloon angioplasty safe and effective in treating lower limb blockages. The main question it aims to answer is: Is tr...

7 locations(Phoenix, San Diego, Gainesville)
224 participants
Angiodynamics, Inc.
View Study Details
RecruitingNCT06926842

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

The main purpose of this study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or obesity and type 2 diabetes....

10 locations(Cullman, Phoenix, Little Rock)
216 participants
Zealand Pharma
View Study Details
RecruitingNCT06032065

SMART Exercise for PAD

Supervised exercise therapy (SET), consisting of treadmill exercise conducted three times weekly at a center while supervised by healthcare personnel, is first line therapy for people disabled by lowe...

3 locations(Chicago, Chicago, Minneapolis)
210 participants
Northwestern University
View Study Details
RecruitingNCT06657976

Response to Exercise and Nitric Oxide in PAD

RESIST PAD is a randomized trial of 200 PAD patients to establish: 1) whether a 12-week exercise intervention significantly increases Δ nitrite at 12-week follow-up, compared to control; 2) whether ex...

2 locations(Chicago, Chicago)
200 participants
Northwestern University
View Study Details
RecruitingNCT05641688

[18F]PI-2620 Phase 3 Histopathological Study

This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with \[18F\]PI-2620 for detection of tau deposition in subjects with Al...

10 locations(Phoenix, Sun City, Los Angeles)
200 participants
Life Molecular Imaging Ltd
View Study Details
RecruitingNCT04046497

Artificial Intelligence to Measure Adherence to Oral Medication

The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis....

5 locations(Hialeah, Grand Rapids, Kalamazoo)
200 participants
Northwell Health
View Study Details
RecruitingNCT02305654

International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)

This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a series of questions that routinely arise in the sequencing of t...

10 locations(Los Angeles, Los Angeles, Tampa)
200 participants
Institute of Cancer Research, United Kingdom
View Study Details
RecruitingNCT03765567

Placement of Antibiotic Powder in Wounds During the Emergency Room

This is the first prospective controlled study to determine whether the topical application of vancomycin powder reduces infection-related complications when applied to open fracture injuries in the a...

2 locations(San Antonio, San Antonio)
200 participants
The University of Texas Health Science Center at San Antonio
View Study Details
RecruitingNCT06111586

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

This is a randomized, parallel group, double-blind Phase 2 study with a 52-week blinded extension evaluating the safety and efficacy of 3 dose levels of frexalimab in comparison with placebo in partic...

10 locations(San Francisco, Denver, Gainesville)
192 participants
Sanofi
View Study Details
RecruitingNCT04794530

The COCOA-PAD II Trial

Among people with peripheral artery disease (PAD) age 55 and older, the investigators will test the hypothesis that PAD participants randomized to cocoa flavanols will have greater improvement or less...

3 locations(Chicago, Chicago, Minneapolis)
190 participants
Northwestern University
View Study Details
RecruitingNCT05762107

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

The goal of this clinical trial is to learn about the effect of the study drug (ZT-01) on low blood sugar (hypoglycemia) in adults with type 1 diabetes (T1D) who have been having low blood sugars ("hy...

10 locations(Escondido, Los Angeles, San Carlos)
186 participants
Zucara Therapeutics Inc.
View Study Details
RecruitingNCT06690398

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability associated with Autism Spectrum Disorder (AS...

10 locations(Dothan, Peoria, Phoenix)
174 participants
Intra-Cellular Therapies, Inc.
View Study Details
RecruitingNCT06706674

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irritability associated with Autism Spectrum Disorder (AS...

10 locations(Little Rock, Imperial, Sacramento)
174 participants
Intra-Cellular Therapies, Inc.
View Study Details
RecruitingNCT06722235

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Primary immune thrombocytopenia (ITP) is a condition where the immune system mistakenly destroys platelets, which are cells that help stop bleeding. This leads to a low number of platelets, making it ...

10 locations(Los Angeles, Denver, Washington D.C.)
171 participants
Takeda
View Study Details
RecruitingNCT03937154

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer, or breast cancer measured by the ability to administer o...

10 locations(Jonesboro, Anaheim, Orange)
162 participants
Amgen
View Study Details
RecruitingNCT05292339

Ketorolac in Upper Extremity Tendinopathy and Arthropathy

Osteoarthritis (OA) and inflammatory conditions of the tendons and joints of the shoulder, elbow, hand, and wrist are common yet disabling diseases. Standard management utilizes conservative measures ...

4 locations(Atlanta, Atlanta, Atlanta)
160 participants
Emory University
View Study Details
RecruitingNCT06042153

DIALYSIS-TIR Study

This study will look at control of blood sugar levels in persons with type 2 diabetes mellitus currently on chronic dialysis. Researchers will compare blood sugar levels in people taking semaglutide t...

5 locations(Chapel Hill, Dallas, Dallas)
157 participants
University of Texas Southwestern Medical Center
View Study Details
RecruitingNCT06525077

Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)

This is a double-blind, placebo-controlled, randomized withdrawal, multicenter study of the efficacy and safety of FT218. FT218 drug product is a once-nightly formulation of sodium oxybate for extende...

7 locations(Boulder, Winter Park, Stockbridge)
150 participants
Avadel
View Study Details
RecruitingNCT05081245

ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)

ML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and adult subjects with ASD. The primary objective is to ...

10 locations(Dothan, Phoenix, Glendale)
150 participants
MapLight Therapeutics
View Study Details
RecruitingNCT06712823

An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894

The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of atumelnant (CRN04894)....

9 locations(Minneapolis, Morehead City, Córdoba)
150 participants
Crinetics Pharmaceuticals Inc.
View Study Details
RecruitingNCT06056297

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

The purpose of this study is to demonstrate the efficacy and evaluate the safety and tolerability of mavorixafor in participants with congenital or acquired primary autoimmune and idiopathic chronic n...

10 locations(Phoenix, La Jolla, Torrance)
150 participants
X4 Pharmaceuticals
View Study Details
RecruitingNCT06217302

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Wheth...

10 locations(Stanford, Aurora, Chicago)
150 participants
Alessandro Doria
View Study Details
RecruitingNCT06334133

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....

10 locations(Escondido, La Jolla, Englewood)
150 participants
vTv Therapeutics
View Study Details
RecruitingNCT06480760

Effects of Carnosine In Patients With Peripheral Arterial Disease Patients

The purpose of this study is to determine whether carnosine (a food ingredient found in chicken and red meat) supplementation (2 g) for 6 months in participants with non-claudication and claudication ...

3 locations(Louisville, Louisville, Louisville)
144 participants
Shahid Baba
View Study Details
RecruitingNCT06880770

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

This study will evaluate the efficacy and safety of plozasiran in approximately 140 adult participants with severe hypertriglyceridemia (SHTG) and history of at least two prior acute pancreatitis (AP)...

7 locations(Santa Clarita, Springfield, North Platte)
140 participants
Arrowhead Pharmaceuticals
View Study Details

Top Cities for Pulmonary Embolism Clinical Trials

Pulmonary Embolism clinical trials are recruiting across 317 cities. Here are the cities with the most active studies:

About Pulmonary Embolism

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

Clinical trials are advancing new treatments for pulmonary embolism. Currently, 100 studies are recruiting a combined 61,015 participants across the United States. Research is being conducted by 72 organizations including Boehringer Ingelheim, Brigham and Women's Hospital, Pfizer and 69 others.

2026 Pulmonary Embolism Research Landscape

As of March 2026, the pulmonary embolism clinical trial landscape includes 100 actively recruiting studies across 317 cities in the United States. These studies are collectively seeking 61,015 participants, with an average enrollment target of 610 per study.

Research is being led by 72 different organizations, including Boehringer Ingelheim, Brigham and Women's Hospital, Pfizer, AbbVie, Major Extremity Trauma Research Consortium, and 67 others. The large number of sponsors reflects significant research interest and investment in pulmonary embolism treatment advancement.

Geographically, pulmonary embolism trials are most concentrated in Los Angeles, California (27 trials); Birmingham, Alabama (23 trials); Phoenix, Arizona (20 trials); Atlanta, Georgia (20 trials); Chicago, Illinois (17 trials) and 7 other cities.

Featured Pulmonary Embolism Studies

Highlighted recruiting studies for pulmonary embolism, selected by enrollment size and research scope.

RecruitingNCT07064473

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empagliflozin, helps reduce cardiovascular risk in people with these conditions. The study will compare this ...

Sponsor: Boehringer Ingelheim· 11,800 participants· 10 locations (Anniston, Fairhope, Guntersville, Chandler)
View full study details →
RecruitingNCT05390892

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients with type 2 diabetes (T2D) and either established atherosclerotic cardiovascular disease (ASCVD) or at high risk for ASCVD. To accomplish this objective, we will randomly assign 6,000 patients with e...

Sponsor: Brigham and Women's Hospital· 6,000 participants· 8 locations (Baltimore, Duluth, Columbia, New York)
View full study details →
RecruitingNCT04649242

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.

Sponsor: Pfizer· 2,100 participants· 10 locations (Birmingham, Scottsdale, Tempe, Anaheim)
View full study details →

Frequently Asked Questions About Pulmonary Embolism Clinical Trials

Are there pulmonary embolism clinical trials near me?

Yes, there are 100 pulmonary embolism clinical trials currently recruiting across 317+ cities in the United States, including Los Angeles, California; Birmingham, Alabama; Phoenix, Arizona. Browse the studies above to find one at a location convenient for you.

How do I join a pulmonary embolism clinical trial?

To join a pulmonary embolism clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.

Are pulmonary embolism clinical trials free?

Yes, participation in pulmonary embolism clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.

What types of pulmonary embolism treatments are being studied?

Current pulmonary embolism clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 72 research organizations.

Is it safe to participate in pulmonary embolism clinical trials?

Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.

Data updated March 2, 2026 from ClinicalTrials.gov

About This Data

Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.

Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.

Page reviewed by the HelloStudys Research Team · Last updated March 2, 2026 · Data from ClinicalTrials.gov